Items where Author is "Abolhassani, H."

(2025) Decreased expression of hsa-miR-142-3p and hsa-miR-155-5p in common variable immunodeficiency and involvement of their target genes and biological pathways. Allergologia Et Immunopathologia. pp. 153-169. ISSN 0301-0546

(2025) Exploring Monogenic, Polygenic, and Epigenetic Models of Common Variable Immunodeficiency. Human Mutation. ISSN 10597794 (ISSN)

(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)

(2024) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2204-2256. ISSN 0140-6736

(2024) COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. Journal of Clinical Immunology. p. 17. ISSN 0271-9142

(2024) Clinical heterogeneity in families with multiple cases of inborn errors of immunity. Clinical Immunology. p. 11. ISSN 1521-6616

(2024) Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 1989-2056. ISSN 0140-6736

(2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2162-2203. ISSN 0140-6736

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2100-2132. ISSN 0140-6736

(2024) Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. pp. 1199-1226. ISSN 01406736 (ISSN)

(2024) Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2057-2099. ISSN 0140-6736

(2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2133-2161. ISSN 0140-6736

(2024) Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infectious Diseases. pp. 698-725. ISSN 1473-3099

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency. Journal of Investigational Allergology and Clinical Immunology. pp. 233-245. ISSN 1018-9068

(2024) Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Regional Health - Southeast Asia. p. 26. ISSN 2772-3682

(2024) The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Global Health. E960-E982. ISSN 2214-109X

(2023) Autoimmune versus Non-autoimmune Cutaneous Features in Monogenic Patients with Inborn Errors of Immunity. Biology-Basel. p. 14.

(2023) Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Frontiers in Oncology. ISSN 2234943X (ISSN)

(2023) Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. Eclinicalmedicine. p. 22.

(2023) Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Global Health. E385-E413. ISSN 2214-109X

(2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy: European Journal of Allergy and Clinical Immunology. pp. 2232-2254. ISSN 01054538 (ISSN)

(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736

(2023) Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 685-711. ISSN 1474-4422

(2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. Eclinicalmedicine. p. 23.

(2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematology. e713-e734. ISSN 2352-3026

(2023) The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet. pp. 313-335. ISSN 0140-6736

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA oncology. pp. 420-444. ISSN 2374-2445 (Electronic) 2374-2437 (Print) 2374-2437 (Linking)

(2022) Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. pp. 420-444. ISSN 2374-2437 (Print) 2374-2437

(2022) Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry. Clinical Immunology. p. 16. ISSN 1521-6616

(2022) Diversity of malignancies in patients with different types of inborn errors of immunity. Allergy Asthma and Clinical Immunology. p. 9. ISSN 1710-1492

(2022) Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency. JOURNAL OF CLINICAL IMMUNOLOGY. pp. 634-652. ISSN 0271-9142 1573-2592 J9 - J CLIN IMMUNOL

(2022) Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency. Journal of Clinical Immunology. S43-S43. ISSN 0271-9142

(2022) The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS). Immunological Investigations. pp. 644-659. ISSN 08820139 (ISSN)

(2022) Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. Bmj-British Medical Journal. p. 15. ISSN 0959-535X

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019. LANCET INFECTIOUS DISEASES. pp. 222-241. ISSN 1473-3099 1474-4457 J9 - LANCET INFECT DIS

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. pp. 222-241. ISSN 14733099 (ISSN)

(2022) Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. Journal of Experimental Medicine. p. 33. ISSN 0022-1007

(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. SCIENTIFIC REPORTS. ISSN 20452322 (ISSN)

(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Scientific Reports. ISSN 20452322 (ISSN)

(2022) Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019. Archives of Iranian Medicine. pp. 767-778. ISSN 10292977 (ISSN)

(2022) Role of rare immune cells in common variable immunodeficiency. PEDIATRIC ALLERGY AND IMMUNOLOGY. ISSN 0905-6157 1399-3038 J9 - PEDIAT ALLERG IMM-UK

(2022) The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET ONCOLOGY. pp. 27-52. ISSN 1470-2045 1474-5488 J9 - LANCET ONCOL

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736

(2021) Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine. pp. 1761-1782. ISSN 10788956 (ISSN)

(2021) Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Pediatr Allergy Immunol. pp. 1335-1348. ISSN 0905-6157

(2021) Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET. pp. 1593-1618. ISSN 0140-6736 1474-547X J9 - LANCET

(2021) Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. LANCET. pp. 870-905. ISSN 0140-6736 1474-547X J9 - LANCET

(2021) Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency. Journal of Clinical Immunology. pp. 345-355. ISSN 0271-9142

(2021) Mapping routine measles vaccination in low- and middle-income countries. Nature. 415-+. ISSN 0028-0836

(2021) Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050. LANCET. pp. 1317-1343. ISSN 0140-6736 1474-547X J9 - LANCET

(2020) Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. Blood. pp. 2638-2655. ISSN 0006-4971

(2020) Five insights from the Global Burden of Disease Study 2019. Lancet. pp. 1135-1159. ISSN 0140-6736

(2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. pp. 1160-1203. ISSN 01406736 (ISSN)

(2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 1204-1222. ISSN 0140-6736

(2020) Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. pp. 1223-1249. ISSN 01406736 (ISSN)

(2020) Global systematic review of primary immunodeficiency registries. Expert Review of Clinical Immunology. pp. 717-732. ISSN 1744-666X

(2020) Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. Nature Medicine. pp. 750-759. ISSN 1078-8956

(2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 1250-1284. ISSN 0140-6736

(2020) Monogenic Primary Immunodeficiency Disorder Associated with Common Variable Immunodeficiency and Autoimmunity. International Archives of Allergy and Immunology. pp. 706-714. ISSN 1018-2438

(2019) Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. ISSN 2213-2201 (Electronic)

(2019) Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran. Immunology Letters. pp. 70-78. ISSN 0165-2478

(2019) The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis. Pediatr Allergy Immunol. pp. 469-478. ISSN 1399-3038 (Electronic) 0905-6157 (Linking)

(2018) Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. The Journal of allergy and clinical immunology. pp. 1450-1458. ISSN 1097-6825 (Electronic) 0091-6749 (Linking)

(2018) Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis. Journal of Clinical Immunology. pp. 816-832. ISSN 0271-9142

(2017) Approach to the Management of Autoimmunity in Primary Immunodeficiency. Scandinavian Journal of Immunology. pp. 13-29. ISSN 0300-9475

(2017) Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Review of Clinical Immunology. pp. 101-115. ISSN 1744-666X

(2017) Cernunnos deficiency associated with BCG adenitis and autoimmunity: First case from the national Iranian registry and review of the literature. Clinical Immunology. pp. 201-206. ISSN 1521-6616

(2017) Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study. Pediatric Allergy and Immunology. pp. 478-484. ISSN 0905-6157

(2017) Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients. Endocrine Metabolic & Immune Disorders-Drug Targets. pp. 134-140. ISSN 1871-5303

(2017) A Comparison of Clinical and Immunologic Phenotypes in Familial and Sporadic Forms of Common Variable Immunodeficiency. Scandinavian Journal of Immunology. pp. 239-247. ISSN 0300-9475

(2017) Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergologia Et Immunopathologia. pp. 602-615. ISSN 0301-0546

(2017) Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency. Clinical Immunology. pp. 124-132. ISSN 1521-6616

(2017) Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders. Journal of Investigational Allergology and Clinical Immunology. pp. 213-224. ISSN 1018-9068

(2017) New therapeutic approach by sirolimus for enteropathy treatment in patients with LRBA deficiency. European Annals of Allergy and Clinical Immunology. pp. 235-239. ISSN 1764-1489

(2017) Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (CVID). Endocrine Metabolic & Immune Disorders-Drug Targets. pp. 332-340. ISSN 1871-5303

(2017) Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scandinavian Journal of Immunology. pp. 3-12. ISSN 0300-9475

(2016) Asthma and Allergic Diseases in a Selected Group of Patients With Common Variable Immunodeficiency. Journal of Investigational Allergology and Clinical Immunology. pp. 209-211. ISSN 1018-9068

(2016) Autoimmunity in primary T-cell immunodeficiencies. Expert Review of Clinical Immunology. pp. 989-1006. ISSN 1744-666X

(2016) Autoimnriunity in Primary Antibody Deficiencies. International Archives of Allergy and Immunology. pp. 180-193. ISSN 1018-2438

(2016) Evaluation of Known Defective Signaling-Associated Molecules in Patients Who Primarily Diagnosed as Common Variable Immunodeficiency. International Reviews of Immunology. pp. 7-24. ISSN 0883-0185

(2016) Important Factors Influencing Severity of Common Variable Immunodeficiency. Archives of Iranian Medicine. pp. 544-550. ISSN 1029-2977

(2016) Lymphocytic Interstitial Pneumonitis: An Unusual Presentation of X-Linked Hyper Ig M Syndrome. Iranian Journal of Pediatrics. ISSN 2008-2142

(2016) Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency. Molecular Immunology. pp. 1-9. ISSN 0161-5890

(2016) Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014. Emerging Infectious Diseases. pp. 1712-1719. ISSN 1080-6040

(2016) The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases. Endocrine Metabolic & Immune Disorders-Drug Targets. pp. 80-88. ISSN 1871-5303

(2015) Clinical phenotype classification for selective immunoglobulin A deficiency. Expert Review of Clinical Immunology. pp. 1245-1254. ISSN 1744-666X

(2015) Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment. Journal of Investigational Allergology and Clinical Immunology. pp. 416-425. ISSN 1018-9068